Medgenics (MDGN) Narrows Q3 Loss
Tweet
Share
E-mailGet Alerts mdgn Hot Sheet
Join SI Premium – FREE
Medgenics (NYSE: MDGN) reported Q3 EPS of ($0.21), versus ($0.33) reported last year.
For earnings history and earnings-related data on Medgenics (MDGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
- Rockstar Energy founder seeks CEO role at Celsius Holdings
- Celsius jumps 12% as Rockstar founder builds 4.7% stake, demands CEO ouster
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
